NCT03841630View on ClinicalTrials.gov

A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 13, 2019

Primary Completion Date

July 25, 2019

Study Completion Date

July 25, 2019

Conditions
Healthy
Interventions
DRUG

LY3437943

Administered subcutaneously (SC)

DRUG

Placebo

Administered SC

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03841630 - A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants | Biotech Hunter | Biotech Hunter